Adial Pharmaceuticals, Inc. held its 2023 Annual Meeting of Stockholders and stockholders approved Amendment No. 5 to the Company's 2017 Equity Incentive Plan to increase the number of shares of common stock authorized for grant under the plan from 380,000 to 500,000.